T

Tasly Pharmaceutical Group Co., LTD.

31 employees

Tasly Pharmaceutical is a company that provides global market services with tech systems in the GMP.

Investor insights

Sectors invested in

Biotechnology5
Medical5
Health Care3
Immuno-oncology2
Biopharmaceutical2
Drug Development2
Monoclonal antibodies2
Cancer2
Bispecific antibodies2
Antibody2
Biologics2
HIV2
抗病毒2
NASH2
Product Research2
Pharmaceutical2
Medical Device2
Therapeutics2
Confocal Laser Endomicroscopy1
Cellvizio1

Funding rounds participated in

$100M sweet spot round size

Most of their 9 investments are in rounds between $35M and $100M

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Pharmaceutical

Date founded

1994

Investments made

M

Mauna Kea Technologies raised undisclosed on May 31, 2023

Investors: Tasly Pharmaceutical Group Co., LTD.

U

Undisclosed raised $100M on January 7, 2019

Investors: 中金公司, China Capital Investment Group, PingAn Ventures, IDG Capital Partners, LB Investment and Tasly Pharmaceutical Group Co., LTD.

P

PROFUSA raised $45M on August 14, 2018

Investors: 3E Bioventures Capital, Maxim Integrated Products and Tasly Pharmaceutical Group Co., LTD.

I

I-Mab Biopharma raised $220M on June 29, 2018

Investors: Tally Capital, Hillhouse Capital Management, EDBI Pte Ltd, CDH Investments, Hony Capital and Tasly Pharmaceutical Group Co., LTD.

B

BIOTECH CO. raised undisclosed on April 11, 2018

Investors: Tasly Pharmaceutical Group Co., LTD.

I

I-Mab Biopharma raised $150M on March 23, 2017

Investors: Genexine, Inc. and Tasly Pharmaceutical Group Co., LTD.

U

Undisclosed raised $15M on March 22, 2017

Investors: 经纬创投（北京）投资管理顾问有限公司 and Tasly Pharmaceutical Group Co., LTD.

A

Ascletis Pharma Inc. raised $100M on January 3, 2017

Investors: 分众传媒 and Tasly Pharmaceutical Group Co., LTD.

A

Ascletis Pharma Inc. raised $35M on September 2, 2015

Investors: Tasly Pharmaceutical Group Co., LTD.

FAQ